Providence Saint Johns Health Center
Santa Monica, California 90404
6 studies enrolling now · 29 studies all time
What they study most
Acral Melanoma, Addiction, Advanced Melanoma, Advanced Solid Tumor, Atrial Fibrillation, BRAF Gene Mutation, Basal Cell Carcinoma, Benign Liver Tumor, Biochemical Recurrence of Malignant Neoplasm of Prostate, Biofilm Formation, Bladder Cancer, Brain Metastases
Studies at this site
- A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer — Recruiting now
- A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer — Recruiting now
- Real-world Evaluation of the HistoSonics Edison System for Treatment of Liver Tumors Across Multidisciplinary Users (BOOMBOX: Master Study) — Recruiting now
- Copper Cu 64 PSMA I&T PET Imaging in Men With Newly Diagnosed Prostate Cancer — Recruiting now
- A Study of Assessment on Safety and Effectiveness of BWI Pulsed Field Ablation With OMNYPULSE Catheter for the Treatment of Paroxysmal Atrial Fibrillation (PAF) — Recruiting now
- A Beta-only IL-2 ImmunoTherapY Study — Recruiting now
- Pembrolizumab and Pemetrexed for Progressive Chordoma — Recruiting now
- Nipocalimab in Moderate to Severe Sjogren's Disease — Running, not enrolling
- A Study of TAR-200 in Combination With Cetrelimab Versus Concurrent Chemoradiotherapy in Participants With Muscle-invasive Bladder Cancer (MIBC) of the Bladder — Running, not enrolling
- A Study of AdAPT-001 in Subjects With Sarcoma and Refractory Solid Tumors — Running, not enrolling
- Expanded Access to Ulixertinib (BVD-523) in Patients With Advanced MAPK Pathway-Altered Malignancies — Available (expanded access)
- Study of PF-07220060 With Letrozole in Adults With HR-positive HER2-negative Breast Cancer Who Have Not Received Anticancer Treatment for Advanced/Metastatic Disease — Running, not enrolling
- Copper Cu 64 PSMA I&T PET Imaging in Men With Suspected Recurrence of Prostate Cancer — Completed
- A Study of Botensilimab (AGEN1181) for the Treatment of Advanced Melanoma — Running, not enrolling
- Infusion Duration Study To Assess Tolerability of Pegloticase Administered With a Shorter Infusion Duration in Subjects With Uncontrolled Gout Receiving Methotrexate — Completed
- Intermediate-size Expanded Access to ONC201 for Patients With H3 K27M-mutant and/or Midline Gliomas — APPROVED_FOR_MARKETING
- 177Lu-PSMA-I&T for Metastatic Castration-Resistant Prostate Cancer — Running, not enrolling
- Collaboration Leading to Addiction Treatment and Recovery From Other Stresses — Completed
- Study of Magrolimab in Patients With Solid Tumors — Stopped early
- TAEK-VAC-HerBy Vaccine for Brachyury and HER2 Expressing Cancer — Completed
- Randomized Study of Silq Urinary Catheter — Completed
- Competitive Revision for CLARO: Collaboration Leading to Addiction Treatment and Recovery From Other Stresses — Completed
- Clinical Utility of FES F18 PET/CT in Metastatic Breast Cancer Patients — Stopped early
- A Phase 3 Study of UGN-102 for Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer — Stopped early
- Recurrent GBM Treated With Neurosurgical Resection and IORT Using the Xoft Axxent eBx System and Bevacizumab — Stopped early
- A Study of Modified Stem Cells in Traumatic Brain Injury (TBI) — Completed
- Dose-Escalation Study of RRx-001 in Combination With Whole Brain Radiation in Subjects With Brain Metastases — Completed
- Stress Management for Cancer Patients: How Well Does it Work? (C2H-D) — Completed
- A Study to Optimize Care for Lung Cancer Patients Undergoing Video-Assisted Thoracoscopic Surgery (VATS) — Completed